Literature DB >> 24656806

PTEN function: the long and the short of it.

Benjamin D Hopkins1, Cindy Hodakoski1, Douglas Barrows1, Sarah M Mense1, Ramon E Parsons2.   

Abstract

Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a phosphatase that is frequently altered in cancer. PTEN has phosphatase-dependent and -independent roles, and genetic alterations in PTEN lead to deregulation of protein synthesis, the cell cycle, migration, growth, DNA repair, and survival signaling. PTEN localization, stability, conformation, and phosphatase activity are controlled by an array of protein-protein interactions and post-translational modifications. Thus, PTEN-interacting and -modifying proteins have profound effects on the tumor suppressive functions of PTEN. Moreover, recent studies identified mechanisms by which PTEN can exit cells, via either exosomal export or secretion, and act on neighboring cells. This review focuses on modes of PTEN protein regulation and ways in which perturbations in this regulation may lead to disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PI3K signaling; PTEN; PTEN-Long

Mesh:

Substances:

Year:  2014        PMID: 24656806      PMCID: PMC4043120          DOI: 10.1016/j.tibs.2014.02.006

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  123 in total

1.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

Authors:  M Tamura; J Gu; K Matsumoto; S Aota; R Parsons; K M Yamada
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

2.  TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.

Authors:  D M Li; H Sun
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

3.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

4.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

5.  PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway.

Authors:  M Tamura; J Gu; E H Danen; T Takino; S Miyamoto; K M Yamada
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

6.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.

Authors:  E M Arch; B K Goodman; R A Van Wesep; D Liaw; K Clarke; R Parsons; V A McKusick; M T Geraghty
Journal:  Am J Med Genet       Date:  1997-09-05

8.  Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.

Authors:  D J Marsh; P L Dahia; V Coulon; Z Zheng; F Dorion-Bonnet; K M Call; R Little; A Y Lin; R A Eeles; A M Goldstein; S V Hodgson; A L Richardson; B G Robinson; H C Weber; M Longy; C Eng
Journal:  Genes Chromosomes Cancer       Date:  1998-01       Impact factor: 5.006

9.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function.

Authors:  M P Myers; I Pass; I H Batty; J Van der Kaay; J P Stolarov; B A Hemmings; M H Wigler; C P Downes; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  103 in total

Review 1.  Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.

Authors:  Benjamin D Hopkins; Ramon E Parsons
Journal:  Clin Cancer Res       Date:  2014-11-01       Impact factor: 12.531

2.  Mechanism of action studies of lomaiviticin A and the monomeric lomaiviticin aglycon. Selective and potent activity toward DNA double-strand break repair-deficient cell lines.

Authors:  Laureen C Colis; Denise C Hegan; Miho Kaneko; Peter M Glazer; Seth B Herzon
Journal:  J Am Chem Soc       Date:  2015-04-22       Impact factor: 15.419

3.  The Mechanism of Action of (-)-Lomaiviticin A.

Authors:  Seth B Herzon
Journal:  Acc Chem Res       Date:  2017-09-28       Impact factor: 22.384

4.  Phosphorylated insulin-like growth factor-1 receptor expression predicts poor prognosis of Chinese patients with gastric cancer.

Authors:  Wen-ying Deng; Ning Li; Xiang-bin Wan; Su-xia Luo; You-wei Zhang
Journal:  Med Oncol       Date:  2014-10-28       Impact factor: 3.064

5.  Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN.

Authors:  Xiang Xia; Kundong Zhang; Guangtao Luo; Gang Cen; Jun Cao; Kejian Huang; Zhengjun Qiu
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

Review 6.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

7.  Characterization of FOXO1, 3 and 4 transcription factors in ovaries of fetal, prepubertal and adult rhesus macaques.

Authors:  Alison Y Ting; Mary B Zelinski
Journal:  Biol Reprod       Date:  2017-05-01       Impact factor: 4.285

Review 8.  Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.

Authors:  Hui Jun Lim; Philip Crowe; Jia-Lin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-22       Impact factor: 4.553

9.  Involvement of IGF-2, IGF-1R, IGF-2R and PTEN in development of human tooth germ - an immunohistochemical study.

Authors:  Darko Kero; Livia Cigic; Ivana Medvedec Mikic; Tea Galic; Mladen Cubela; Katarina Vukojevic; Mirna Saraga-Babic
Journal:  Organogenesis       Date:  2016-06-21       Impact factor: 2.500

10.  Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders.

Authors:  Sean B Johnston; Ronald T Raines
Journal:  Biochemistry       Date:  2015-02-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.